Profile
Beth A.
Burnside worked as a Vice President at Shire Laboratories, Inc. from 1993 to 2002.
She then worked as a Senior VP of Regulatory Affairs & Compliance at Guardian Medical Solutions Ltd.
before becoming the SVP of Regulatory Affairs & Strategic Planning at Middlebrook Pharmaceuticals, Inc. from 2002 to 2009.
Burnside holds an undergraduate degree from Muhlenberg College and a graduate and doctorate degree from Drexel University.
Former positions of Beth A. Burnside
| Companies | Position | End |
|---|---|---|
| QRXPHARMA LTD. | Compliance Officer | 16/01/2015 |
Middlebrook Pharmaceuticals, Inc.
 Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX. | Chief Tech/Sci/R&D Officer | 03/08/2009 |
Shire Laboratories, Inc.
 Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Shire Laboratories was a specialty pharmaceutical company focused on developing products for its own portfolio and in partnership with other companies, using its technologies and development capabilities. The company products include CollaGenex, Indevus, Shire and United Therapeutics. Its key technologies are ProScreen, OptiScreen , Microtrol, Solutrol and EnSoTrol, for bioavailability enhancement and oral controlled release, and Avert for reduced-abuse potential. Shire Laboratories was headquartered in Rockville, MD. | Corporate Officer/Principal | 01/01/2002 |
Training of Beth A. Burnside
| Drexel University | Doctorate Degree |
| Muhlenberg College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX. | Health Technology |
Guardian Medical Solutions Ltd.
 Guardian Medical Solutions Ltd. Pharmaceuticals: MajorHealth Technology Guardian Medical Solutions Ltd. engages in the development and commercialization of biopharmaceutical products. The company was founded by Michael Anthony Quinn and Felix de la Iglesia on September 19, 2002 and is headquartered in Sydney, Australia. | Health Technology |
Shire Laboratories, Inc.
Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Shire Laboratories was a specialty pharmaceutical company focused on developing products for its own portfolio and in partnership with other companies, using its technologies and development capabilities. The company products include CollaGenex, Indevus, Shire and United Therapeutics. Its key technologies are ProScreen, OptiScreen , Microtrol, Solutrol and EnSoTrol, for bioavailability enhancement and oral controlled release, and Avert for reduced-abuse potential. Shire Laboratories was headquartered in Rockville, MD. | Commercial Services |
- Stock Market
- Insiders
- Beth A. Burnside
